Last Updated on November 14, 2019 by Kevin Douglass
Bellicum Pharmaceuticals (NASDAQ: BLCM) has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bottom (starting Aug 2019 to current) and with very successful Biotech investor funds e.g. Perceptive Advisors and Baker Bro’s starting positions makes an interesting case for retail investors to follow the money and also make starter position with sidelined cash. Read below for what we’ll be on the watch for.
Current setup -> Watching for breakout of wedge.
Breaks above $1.02 watch for continued run to $1.24.
Bullish Harmonic Gartley provides me sufficient reason to start a swing position.
Disclosure: I am long BLCM. This is not a recommendation to buy/sell as I am NOT a financial adviser. Please do your homework before investing.